ARCHIVES

User Fees Proposed For FDA Oversight Services; Industry Groups Call It “Tax On Innovations”

This article is from The Cancer Letter archive.

Vol. 15 No. 03 | January 20, 1989

Download PDF Visit The Full Archive

Related Articles

In Brief: Owens New President Of AACI, Yates President Elect; UNC Gains Comprehensive Center Status

June 29, 1990

A History of NCCN

January 13, 2012

ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.

June 9, 2006

Toxic Substance Act Would Affect Cancer Program

March 21, 1975

Symposium Planned On Grantmanship

April 20, 1984

FDA Authority To Regulate Off-Label Promotion Challenged In Federal Court.

January 15, 2010